Ablynx Announces Q1 2013 Business Update
GHENT, BELGIUM--(Marketwired - May 15, 2013) - Ablynx (EURONEXT BRUSSELS: ABLX), the Belgian-based biopharmaceutical company focused on the discovery and development of Nanobodies® for the...(more)
Ablynx
May 15, 2013 02:22 ET